Bromadol BDPC, an recently man-made pain reliever, exhibits distinctive chemical properties. This compound mainly functions by an partial μ-opioid receptor activator, but shows considerable activity at the kappa binding site as also. The dual effect leads to to the intricate profile regarding consequences, including pain reduction, drowsiness,